China Biologic Products Holdings, Inc. (CBPO) News

China Biologic Products Holdings, Inc. (CBPO)

Today's Latest Price: $107.66 USD

1.56 (1.47%)

Updated Jul 7 3:32pm

Add CBPO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 115 in China

See all "A" rated Strong Buy stocks

Filter CBPO News Items

CBPO News Results

Event/TimeSymbolCompanyNews DetailStartEndChangePOWR Rating
Loading, please wait...

Latest CBPO News From Around the Web

Below are the latest news stories about China Biologic Products Holdings Inc that investors may wish to consider to help them evaluate CBPO as an investment opportunity.

5 Health Care Stocks Boosting Earnings

Biogen tops the list Continue reading...

Yahoo | June 30, 2020

China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today declared that the Company disagrees with the notice delivered by Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan") to China Biologic, which attempts to terminate the cooperation between China Biologic and Xinjiang Deyuan, and urges Xinjiang Deyuan to cure its breaches and continue to perform its obligations under its cooperation agreement with China Biologic. In addition, the Company announced that, through the lawsuits it previously filed against Xinjiang Deyuan, the Company is seeking monetary claims totaling over RMB460 million and has obtained judicial freezing of certain s...

Yahoo | June 29, 2020

Hedge Funds Are Selling China Biologic Products Holdings Inc (CBPO)

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

Yahoo | June 26, 2020

China Biologic Products Inc (CBPO) Q1 2020 Earnings Call Transcript

An earnings release is available on the Company's website. Today, you will hear from China Biologic's Chairman and CEO, Mr. Joseph Chow, who will start off the call with a review of the Company's basic operating results and report recent developments for the Company. China Biologic's CFO, Mr. Ming Yang, will be available during the Q&A session following the prepared remarks.

Yahoo | May 21, 2020

China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today declared that Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan"), China Biologic's source plasma supplier and cooperation partner, has materially breached its strategic cooperation with China Biologic by entering into plasma supply arrangements with Southern Shuanglin Bio-Pharmacy Co., Ltd. ("Shuanglin"), and that China Biologic will take all necessary measures to protect its rights.

Yahoo | May 20, 2020

China Biologic Reports Financial Results for the First Quarter of 2020

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited financial results for the first quarter of 2020.

Yahoo | May 20, 2020

China Biologic Products to Report First Quarter 2020 Financial Results

China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its first quarter 2020 financial results on Wednesday, May 20, 2020 after the market closes.

Yahoo | May 12, 2020

Thinking about trading options or stock in Boeing, China Biologic Products, FedEx, Intel, or JPMorgan?

NEW YORK, April 8, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BA, CBPO, FDX, INTC, and JPM. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different…

PR Newswire | April 8, 2020

Hedge Funds Are Buying China Biologic Products Inc (CBPO)

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]

Yahoo Finance | April 5, 2020

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019

China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2019.

Yahoo | March 12, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6391 seconds.